AstraZeneca: News

AstraZeneca's antibody cocktail Evusheld effective against Omicron, finds study

AstraZeneca COVID-19 antibody cocktail, Evusheld, effectively works against the Omicron variant of coronavirus, the company said Thursday citing a lab study.

03 Dec 2021

Pfizer

COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective

Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.

03 Sep 2021

North Korea

Kim orders tougher virus steps after North Korea shuns vaccines

North Korean leader Kim Jong Un ordered officials to wage a tougher epidemic prevention campaign after he turned down some foreign COVID-19 vaccines offered via the UN-backed immunization program.

05 Aug 2021

COVID-19

COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll

Mattel, the maker of the Barbie doll, has created a doll to honor Professor Sarah Gilbert, who led the development of the Oxford University and AstraZeneca COVID-19 vaccine.

04 Aug 2021

COVID-19

India mulls mixing Covishield, Sputnik doses; no recommendation yet

India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.

17 Jul 2021

France

France allows visitors vaccinated with Indian-made AstraZeneca vaccine

France will now allow international travelers who have received AstraZeneca's Indian-manufactured vaccine into the country starting Sunday.

02 Jul 2021

India

Mix-and-match COVID-19 vaccines: What do studies say?

In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.

24 Jun 2021

Pfizer

Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection

A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

Efforts on to restart AstraZeneca shipments from India: WHO official

The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of COVID-19 vaccines to countries, a senior official at the UN health agency said.

15 Jun 2021

Pfizer

Pfizer, AstraZeneca vaccines protect against Delta variant, says study

Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.

10 Jun 2021

COVID-19 Vaccine

AstraZeneca vaccine linked to small risk of low blood platelets

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.

21 May 2021

England

Two doses of AstraZeneca vaccine 85%-90% effective, real-world data shows

Two doses of the Oxford/AstraZeneca COVID-19 vaccine are around 85 percent to 90 percent effective against the symptomatic disease, Public Health England (PHE) has said, citing a new analysis of real-world data from the roll-out of the shot in the UK.

11 May 2021

Pfizer

AstraZeneca vaccine's single dose reduces death risk by 80%: Data

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.

02 May 2021

Vaccine

COVID-19 vaccine formulas shouldn't be shared with India: Bill Gates

It's a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.

15 Apr 2021

Denmark

Denmark becomes first European country to permanently drop AstraZeneca vaccine

Even as vaccines became the world's biggest hope against the highly contagious coronavirus, Denmark has stopped using the one made by British-Swedish pharma giant AstraZeneca.

AstraZeneca serves legal notice to Serum Institute over vaccine delays

Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.

03 Apr 2021

COVID-19 Vaccination

UK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients

On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.

02 Apr 2021

Sri Lanka

Facing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs

Sri Lanka has temporarily halted its COVID-19 vaccination program as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India (SII), a top health minister has said.

31 Mar 2021

Germany

Germany halts AstraZeneca vaccine use for under-60s over clot fears

Germany will allow general use of the AstraZeneca coronavirus vaccine only for people aged above 60 years, imposing restrictions on younger people taking the jab after several severe cases of blood clots were reported, the German government said on Tuesday.

25 Mar 2021

Vaccine

Amid growing cases, India temporarily halts export of AstraZeneca's vaccine

Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.

22 Mar 2021

Coronavirus

AstraZeneca says US trial data shows vaccine 79% effective

AstraZeneca says advanced trial data from a US study on its COVID-19 vaccine shows it is 79 percent effective.

19 Mar 2021

Europe

AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination

A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.

16 Mar 2021

Italy

Why European countries are halting the AstraZeneca shot

The largest and most influential European countries, like Germany, France, and Italy, have paused the rollout of coronavirus vaccine, developed by the University of Oxford and British-Swedish pharma giant AstraZeneca over blood clot fears.

13 Mar 2021

India

Looking at adverse effects: India on concerns over AstraZeneca vaccine

India is constantly looking at all the adverse side effects as it conducts a massive coronavirus vaccination program, a top medical expert said today.

12 Mar 2021

Denmark

Use of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland

Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.

01 Mar 2021

Coronavirus

AstraZeneca has sold its stake in Moderna for $1 billion

British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.

COVID-19 vaccines: SII to play huge role in mass production

British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

WHO authorizes AstraZeneca's COVID-19 vaccine for emergency use

The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.